Replies to post #1564 on Lisata Therapeutics Inc (LSTA)

[whirlybird]

By September of this year, results should be known in large part from two studies: the Baxter Reserve study for AMI using PCT CD34 cells and the PRESERVE P2 NBS study. Both should be positive because of earlier studies in Europe showing positive results for similar studies. The Baxter study uses injection of cells whereas the NBS study injected stem cells through the coronary artery, so there is a difference in administration.